Akeso Enrolled First Patient in The Phase III Clinical Trial of Ivonescimab in Combination with Chemotherapy for First-Line Treatment of Triple-Negative Breast Cancer
HONG KONG, Feb. 21, 2025 /PRNewswire/ — Akeso, Inc. (9926.HK) ("Akeso" or…
Akamai selected as strategic cloud computing provider by one of the world's largest technology companies, with a multi-year commitment to spend over $100M on cloud infrastructure services